SG11201501020WA - Pharmaceutical composition for increasing content and availability of cyclic adenosine monophosphate in a body and the preparation thereof - Google Patents
Pharmaceutical composition for increasing content and availability of cyclic adenosine monophosphate in a body and the preparation thereofInfo
- Publication number
- SG11201501020WA SG11201501020WA SG11201501020WA SG11201501020WA SG11201501020WA SG 11201501020W A SG11201501020W A SG 11201501020WA SG 11201501020W A SG11201501020W A SG 11201501020WA SG 11201501020W A SG11201501020W A SG 11201501020WA SG 11201501020W A SG11201501020W A SG 11201501020WA
- Authority
- SG
- Singapore
- Prior art keywords
- availability
- preparation
- pharmaceutical composition
- adenosine monophosphate
- cyclic adenosine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2012/080191 WO2014026341A1 (en) | 2012-08-15 | 2012-08-15 | Pharmaceutical composition increasing cyclic amp content and availability in vivo, and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201501020WA true SG11201501020WA (en) | 2015-04-29 |
Family
ID=50101198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201501020WA SG11201501020WA (en) | 2012-08-15 | 2012-08-15 | Pharmaceutical composition for increasing content and availability of cyclic adenosine monophosphate in a body and the preparation thereof |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20150273005A1 (en) |
| EP (1) | EP2886125B1 (en) |
| JP (1) | JP2015524827A (en) |
| KR (1) | KR101797572B1 (en) |
| AU (2) | AU2012387645A1 (en) |
| BR (1) | BR112015003344A2 (en) |
| CA (1) | CA2881348C (en) |
| MX (1) | MX2015001766A (en) |
| PH (1) | PH12015500320A1 (en) |
| RU (1) | RU2625765C2 (en) |
| SG (1) | SG11201501020WA (en) |
| WO (1) | WO2014026341A1 (en) |
| ZA (1) | ZA201500961B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105249086B (en) * | 2015-11-13 | 2018-09-07 | 侯彦国 | A kind of preparation process of the red date concentrated juice of high cAMP contents |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57128632A (en) * | 1981-01-30 | 1982-08-10 | Hiromu Kubota | Addition product of saponin in medicinal ginseng with nannitol and its preparation |
| JPH02188530A (en) * | 1989-01-13 | 1990-07-24 | Tsurataka Tashiro | Carcinostatic agent |
| US6083932A (en) * | 1997-04-18 | 2000-07-04 | Cv Technologies Inc. | Pharmaceutical compositions derived from ginseng and methods of treatment using same |
| JPH11116486A (en) * | 1997-10-13 | 1999-04-27 | Merveille Kk | Massage preparation for local slimming |
| US7083811B2 (en) * | 2001-02-08 | 2006-08-01 | Siloam Hightech Pharm. Co., Ltd. | Herbal composition for the prevention and treatment of dementia |
| CN100509006C (en) * | 2005-03-25 | 2009-07-08 | 北京欧纳尔生物工程技术有限公司 | Pharmaceutical composition for treating depression and making method thereof |
| JP2007230938A (en) * | 2006-03-02 | 2007-09-13 | Toyama Univ | Preventing or improving agent of alzheimer type memory disorder |
| JP5097196B2 (en) * | 2006-04-19 | 2012-12-12 | 劉建▲しゅん▼ | Herbal medicine compositions and methods for their preparation and use |
| CN101190271A (en) * | 2006-12-01 | 2008-06-04 | 张作光 | A set of medicinal compositions for treating melancholia and preparation method |
| TW200920391A (en) * | 2007-11-15 | 2009-05-16 | Chi Yu Fen | Multi-target post-receptor action used in pharmaceutical composition for depression treatment |
| CN101450104A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating anxiety neurosis |
| CN101450120A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating melancholia using ginseng, Chinese date as raw material and preparation method thereof |
| CN101450103A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating hypochondria and anxiety neurosis |
| CA2746663A1 (en) * | 2007-11-30 | 2009-06-11 | Chi, Yu-Fen | Pharmaceutical compositions with a mechanism of multi-target receptor retroaction for treating depression |
| ES2601510T3 (en) * | 2007-11-30 | 2017-02-15 | Chi, Yu-Fen | Pharmaceutical compositions to treat depression and anxiety |
| CN101450070A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Anti-melancholia medicine using Chinese date Camp as raw material |
| CN101450062A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating melancholia using multi-target receptor after-action mechanism |
| AU2007362012B2 (en) * | 2007-11-30 | 2012-03-29 | Chi, Yu-Fen | Pharmaceutical compositions for treating anxiety |
| CN101890032A (en) * | 2009-05-21 | 2010-11-24 | 张作光 | Medicine composition for treating depression with formulation of Rg1, Rb1 and glycyrrhizic acid and preparation method thereof |
| CN101590217B (en) * | 2009-06-29 | 2011-04-06 | 吴清玲 | Chinese medicinal composition for treating dysthymia and preparation method thereof |
| CN102125572A (en) * | 2010-12-30 | 2011-07-20 | 黑龙江珍宝岛药业股份有限公司 | Pharmaceutical composition and application thereof |
-
2012
- 2012-08-15 RU RU2015108387A patent/RU2625765C2/en not_active IP Right Cessation
- 2012-08-15 CA CA2881348A patent/CA2881348C/en not_active Expired - Fee Related
- 2012-08-15 WO PCT/CN2012/080191 patent/WO2014026341A1/en active Application Filing
- 2012-08-15 SG SG11201501020WA patent/SG11201501020WA/en unknown
- 2012-08-15 JP JP2015526849A patent/JP2015524827A/en active Pending
- 2012-08-15 EP EP12882992.6A patent/EP2886125B1/en not_active Not-in-force
- 2012-08-15 KR KR1020157006515A patent/KR101797572B1/en active IP Right Grant
- 2012-08-15 US US14/420,525 patent/US20150273005A1/en not_active Abandoned
- 2012-08-15 MX MX2015001766A patent/MX2015001766A/en active IP Right Grant
- 2012-08-15 AU AU2012387645A patent/AU2012387645A1/en not_active Abandoned
- 2012-08-15 BR BR112015003344-0A patent/BR112015003344A2/en not_active IP Right Cessation
-
2015
- 2015-02-10 ZA ZA2015/00961A patent/ZA201500961B/en unknown
- 2015-02-13 PH PH12015500320A patent/PH12015500320A1/en unknown
-
2016
- 2016-11-08 AU AU2016256704A patent/AU2016256704B2/en not_active Ceased
-
2018
- 2018-07-06 US US16/029,180 patent/US20180311297A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ705363A (en) | 2017-05-26 |
| JP2015524827A (en) | 2015-08-27 |
| EP2886125A4 (en) | 2016-03-23 |
| WO2014026341A1 (en) | 2014-02-20 |
| CA2881348A1 (en) | 2014-02-20 |
| AU2016256704B2 (en) | 2018-08-02 |
| EP2886125A1 (en) | 2015-06-24 |
| KR101797572B1 (en) | 2017-12-12 |
| ZA201500961B (en) | 2016-01-27 |
| AU2012387645A1 (en) | 2015-02-26 |
| MX2015001766A (en) | 2015-06-03 |
| RU2625765C2 (en) | 2017-07-18 |
| BR112015003344A2 (en) | 2018-06-26 |
| RU2015108387A (en) | 2016-10-10 |
| KR20150064728A (en) | 2015-06-11 |
| PH12015500320A1 (en) | 2015-03-30 |
| AU2016256704A1 (en) | 2016-11-24 |
| CA2881348C (en) | 2018-02-20 |
| US20150273005A1 (en) | 2015-10-01 |
| US20180311297A1 (en) | 2018-11-01 |
| EP2886125B1 (en) | 2019-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269054A (en) | A pharmaceutical composition comprising tasimelteon for use in the teratment of non-24 | |
| HK1255336A1 (en) | Pharmaceutical formulations and processes of preparation thereof | |
| HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
| IL252566A0 (en) | Pharmaceutical compositions and methods | |
| EP2891658A4 (en) | Tenofovir prodrug and pharmaceutical uses thereof | |
| GB2509046B (en) | Improvement in or relating to capsules | |
| SG11201403697YA (en) | Accelerator sensor structure and use thereof | |
| ZA201503644B (en) | Antiviral phosphonate analogues and process for preparation thereof | |
| HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
| ZA201306395B (en) | New low side effect pharmaceutical composition containing antituberculosis drugs | |
| IL237322A0 (en) | Solid pharmaceutical compositions containing levothyroxine and their preparation | |
| EP2862575A4 (en) | Application of piceatannol-3'-o-b-d-glucopyranoside in preparation of medicaments for improving microcirculation block | |
| GB2504390B (en) | Nutraceutical and pharmaceutical composition | |
| GB201220914D0 (en) | Improvements in and relating to dynamic splints | |
| HK1213891A1 (en) | Process for the preparation of voriconazole and analogues thereof | |
| IL238059A0 (en) | Pyrolidine derivatives and pharmaceutical compositions containing them | |
| EP2933290A4 (en) | Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex | |
| HK1186106A1 (en) | Pharmaceutical compositions comprising pentoxifylline and prucalopride and medical uses thereof | |
| SG11201501020WA (en) | Pharmaceutical composition for increasing content and availability of cyclic adenosine monophosphate in a body and the preparation thereof | |
| HK1203147A1 (en) | Cosmetic and pharmaceutical uses of saccharides | |
| HRP20180781T1 (en) | Pharmaceutical composition comprising lacidipine and process of preparation | |
| EP2926811A4 (en) | Artemether-containing pharmaceutical composition, preparation, and use thereof | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| HK1207969A1 (en) | Pharmaceutical composition for oral administration with improved dissolution and or absorption | |
| TH1501000773A (en) | Pharmaceutical composition for increasing component dosage and availability of cyclic adenosine monophosphate in vivo and their preparation. |